Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by mercedesmanon Jun 02, 2023 11:34pm
123 Views
Post# 35478137

RE:3X the EBITDA estimates?

RE:3X the EBITDA estimates?

What? No counters to even one of the 5 key points? 


I suggest that is no effective counter - so the FUD workers need to divert attention to lesser matters ( in the grand scheme) 

E.g. " the SP is low because of x,y or z"
Of course it's not because the FUD workers are working hard to make it so, by discouraging any kind of new demand. Ironically it's almost analogous  to the limited efforts made to encourage new US investors to enter the fray and to support or improve the short term SP and thereby lower the cost of capital, and thereby reduce dilution as the Trial completes. 

<< Previous
Bullboard Posts
Next >>